Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Generative AI creates synthetic regulatory DNA sequences for precision gene control

We developed DNA-Diffusion, a generative artificial intelligence (AI) method that creates synthetic regulatory elements showing enhanced activity. Multiple synthetic elements demonstrated superior cell-type-specific expression in computational predictions and episomal assays, and when integrated at AXIN2, a leukemia-protective gene, outperformed naturally occurring protective variants, opening new possibilities for precision gene therapies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: DNA-Diffusion extends generative AI to regulatory element design.

References

  1. Llimos, G. et al. A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation. Nat. Commun. 13, 2042 (2022). This study discovered the protective AXIN2 variant that reduces chronic lymphocytic leukemia progression.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Taskiran, I. I. et al. Cell-type-directed design of synthetic enhancers. Nature 626, 212–220 (2024). This paper pioneered generative adversarial network (GAN)-based generative design of cell-type-specific enhancers, establishing the foundation for distribution-learning approaches that DNA-Diffusion builds upon.

    Article  CAS  PubMed  Google Scholar 

  3. Gosai, S. J. et al. Machine-guided design of cell-type-targeting cis-regulatory elements. Nature 634, 1211–1220 (2024). This study demonstrated convolutional neural network (CNN)-based optimization for regulatory element design, achieving high signal intensity through direct optimization, which DNA-Diffusion complements by maintaining motif diversity without requiring prior transcription factor knowledge.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ho, J., Jain, A. & Abbeel, P. Denoising diffusion probabilistic models. In Proc. 34th International Conference on Neural Information Processing Systems (eds Larochelle, H. et al.) 6840–6851 (2020). This seminal paper introduced the diffusion model framework that we adapted from image generation to DNA sequences.

  5. Kribelbauer-Swietek, J. F. et al. EXTRA-seq: a genome-integrated extended massively parallel reporter assay to quantify enhancer-promoter communication. Preprint at bioRxiv https://doi.org/10.1101/2024.12.08.627402 (2024). This paper presents EXTRA-seq technology, a method that measures how regulatory DNA sequences control gene expression by integrating them into chromosomes and tracking their ability to activate target genes.

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: DaSilva, L. F. et al. Designing synthetic regulatory elements using the generative AI framework DNA-Diffusion. Nat. Genet. https://doi.org/10.1038/s41588-025-02441-6 (2025).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Generative AI creates synthetic regulatory DNA sequences for precision gene control. Nat Genet 58, 18–19 (2026). https://doi.org/10.1038/s41588-025-02443-4

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41588-025-02443-4

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research